Top Back to top

Antithymocyte globulin (ATG) administration in EBMT centres: a descriptive EBMT Survey

Nursing Research Committee
Transplant Complications Working Party (TCWP)
Study type:
Study number:
Type of Stem Cell Treatment:
Short title:
Primary objective:
Bevans et al. (2004) described “a practice guideline for patients receiving Antithymocyte Globulin ‘(Bevans et al, 2004). After more than 30 years of clinical experience with ATG, a review of nursing practice with regard to: ATG preparation, administration and practice protocols in EBMT centers (adult, paediatric and mixed) during Allogeneic HCT conditioning, is overdue. Additionally, it would be useful to know to what extent guidelines have been implemented and whether this level of practice differs between JACIE accredited and non-accredited European centers. We therefore aim to collect this information in order to identify current practice in transplant centers across Europe with a view to making standardized recommendations for future practice.
Key inclusion criteria:
All principal nurses of all centers of the European Society for Blood and Marrow Transplantation (EBMT) will receive an online survey.
Principal investigator:
Corien Eeltink, Lars Klingen Gjaerde
EBMT Study coordinator:
Brian Piepenbroek
Study coordinator email: